| P2093 | author name string | Daniel P | |
| | Dufek J | |
| | Rektor I | |
| | Znojil V | |
| | Kañovský P | |
| | Streitová H | |
| P2860 | cites work | Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia | Q33734698 |
| | Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A. | Q36895200 |
| | Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease. | Q39493097 |
| | Double-blind study of botulinum toxin in spasmodic torticollis | Q39542317 |
| | Physiology of basal ganglia disorders: an overview. | Q40772145 |
| | Activation of the neck muscles from the ipsi- or contralateral hemisphere during voluntary head movements in humans. A reaction-time study | Q41092823 |
| | Abnormalities of short-latency somatosensory evoked potentials in parkinsonian patients | Q43562125 |
| | Trunk and head tremor as isolated manifestations of dystonia | Q43606409 |
| | The N30 component of somatosensory evoked potentials in patients with dystonia | Q44008683 |
| | Abnormalities of parietal and prerolandic somatosensory evoked potentials in Huntington's disease | Q44646237 |
| | Pre- and postcentral somatosensory evoked potentials in Huntington's disease: effects of stimulus repetition rate | Q45290615 |
| | The frontal N30 component of the median-derived SEP in patients with predominantly unilateral Parkinson's disease. | Q45938656 |
| | Abnormalities of somatosensory evoked potentials in spasmodic torticollis | Q48096795 |
| | Transcranial magnetic stimulation of the human brain: responses in muscles supplied by cranial nerves | Q48125675 |
| | Specific gating of the early somatosensory evoked potentials during active movement | Q48182033 |
| | Basal ganglia infarction as a possible cause of cervical dystonia | Q48310097 |
| | Augmented P22-N31 SEP component in a patient with a unilateral space occupying lesion | Q48391682 |
| | Mental movement simulation affects the N30 frontal component of the somatosensory evoked potential | Q48488779 |
| | Magnetic resonance demonstration of intracranial CSF flow in children | Q48531983 |
| | Gating of the early components of the frontal and parietal somatosensory evoked potentials in different sensory-motor interference modalities | Q48634704 |
| | Lesions of the putamen and dystonia: CT and magnetic resonance imaging | Q48649193 |
| | Influence of stimulus repetition rate on cortical somatosensory potentials evoked by median nerve stimulation: Implications for generation mechanisms | Q48663600 |
| | Neurophysiological investigations in patients with head tremor | Q48666921 |
| | Lateralization of the P22/N30 component of somatosensory evoked potentials of the median nerve in patients with cervical dystonia | Q48666930 |
| | Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study | Q48737398 |
| | Astereognosis and dissociated loss of frontal or parietal components of somatosensory evoked potentials in hemispheric lesions. Detailed correlations with clinical signs and computerized tomographic scanning. | Q48800319 |
| | Corticobulbar and corticospinal projections to neck muscle motoneurons in man. A functional study with magnetic and electric transcranial brain stimulation | Q48806454 |
| | Abnormal cortical motor excitability in dystonia | Q48984170 |
| | Striatopallidal and thalamic dystonia. A magnetic resonance imaging anatomoclinical study | Q49099655 |
| | Non-cephalic reference recording of early somatosensory potentials to finger stimulation in adult or aging normal man: differentiation of widespread N18 and contralateral N20 from the prerolandic P22 and N30 components | Q49152747 |
| | Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia | Q57089254 |
| | N30 in PD | Q67241850 |
| | Change in pattern of muscle activity following botulinum toxin injections for torticollis | Q68026765 |
| | Clinical and polymyographic investigation of spasmodic torticollis | Q68066040 |
| | The metabolic topography of idiopathic torsion dystonia | Q70987276 |
| | Activation and suppression of the sternocleidomastoid muscle induced by transcranial magnetic stimulation | Q71117870 |
| | Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave | Q71662422 |
| | Quantitative EMG in botulinum toxin treatment of cervical dystonia. A double-blind, placebo-controlled study | Q71668442 |
| | Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components in Parkinson's disease and in parkinsonism | Q72237251 |
| | Pre- and postcentral cortical somatosensory evoked potentials in hemiparkinsonism | Q72585150 |
| | The abnormality of N30 somatosensory evoked potential in idiopathic Parkinson's disease is unrelated to disease stage or clinical scores and insensitive to dopamine manipulations | Q72618987 |
| | Parkinson's disease and somatosensory evoked potentials: apomorphine-induced transient potentiation of frontal components | Q72643489 |
| | Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor | Q73902576 |
| | Muscle activity changes in spasmodic torticollis after botulinum toxin treatment | Q86856525 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cervical dystonia | Q6152510 |
| P304 | page(s) | 642-651 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Lateralization of the P22/N30 precentral cortical component of the median nerve somatosensory evoked potentials is different in patients with a tonic or tremulous form of cervical dystonia | |
| P478 | volume | 14 | |